Search
EyePoint Pharmaceuticals Inc
EYPTAdd to Watchlist
13.980USD
+0.785+5.95%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.16BMarket Cap
LossP/E TTM
EyePoint Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
31.37M
-27.50%
EPS(YoY)
-3.17
-36.22%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 31.37M, with a year-on-year change of -27.50.
What are the current assets of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its current assets were 328.65M, with a year-on-year change of -14.26.
What are the total assets of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its total assets of EyePoint Pharmaceuticals Inc were 364.00M, with a year-on-year change of -13.02.
What are the total liabilities of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of EyePoint Pharmaceuticals Inc were 57.88M, with a year-on-year change of -29.38.
What is the total equity of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its total equity of EyePoint Pharmaceuticals Inc was 306.11M, with a year-on-year change of -9.03.
What is the net investment of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its net investment of EyePoint Pharmaceuticals Inc was 68.58M, with a year-on-year change of 131.26.
What is the net financing of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its net financing of EyePoint Pharmaceuticals Inc was 173.65M, with a year-on-year change of 5.87.
What is the Earnings Per Share (EPS) of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.17, with a year-on-year change of -36.22.
What is the net margin of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -739.42, with a year-on-year change of -144.49.
What is the gross margin of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 93.41, with a year-on-year change of 2.18.
What is the Return on Equity (ROE) of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -72.19, with a year-on-year change of -66.27.
What is the Return on Assets (ROA) of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.29, with a year-on-year change of -75.25.
What is the operating profit of EyePoint Pharmaceuticals Inc?
According to EyePoint Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -243.43M, with a year-on-year change of -66.90.